explore -WSS

explore

author：entertainment 2025-10-04 03:40:30 - browse：8887

Allergan, Dom Smith/STAT

It wasn’t supposed to work out this way for Brent Saunders.

Four years ago, Saunders was the whiz kid of the pharmaceutical set. At 44, he had created a large pharmaceutical firm, then called Actavis, almost by force of will after engineering more than $100 billion in deals in a two-year span. Then he had swooped in to rescue Botox maker Allergan from the nefarious claws of Valeant Pharmaceuticals, an asset-stripping drug company loved by many on Wall Street but no one with a conscience.

As CEO, he paired his dealmaking with a boyish charm and a willingness to take on big issues that made him seem like a potential spokesman for the whole industry.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Tuskegee Airman Raymond Cassagnol dies at 102

Wikipedia

WSS

Unique patient identifier: Experts argue the benefits, pitfalls

Biden slams SCOTUS affirmative action decision: 'Discrimination still exists in America'

Medicare Advantage plans can’t deny care with AI, CMS warns

Gene therapy for Afghan refugees’ infant will be fully covered

Brazil's Jair Bolsonaro is barred from running for office until 2030

Why CTE doesn’t keep Americans from enjoying the Super Bowl

leisure time

explore

knowledge

Continuity nursing helped my family in our darkest PICU moments

A protest over insulin prices is seen as a fight for life

BioMarin wins approval for gene therapy to treat hemophilia A

Wildfire smoke map: Which US cities are forecast to be impacted by fires burning in Canada

George Santos makes 1st court appearance after pleading not guilty to 13 counts

What’s missing from the debate over nursing home staff minimums

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Supreme Court rules employers must be more accommodating of religious observance

How to save PrEP access — and even expand it

Readout Newsletter: Amgen, Regeneron, BGI Group and more

leisure time

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Readout LOUD: Venture capital, Gilead, and more M&A

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

Devoted Health’s losses in Medicare Advantage persist

Bernie brings in new pharma CEOs to talk drug prices

The CDC's new social media misinformation war

Wikipedia

Wikipedia

hotspot

leisure time